XOMA Royalty Corporation Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Basis of Presentation and Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Castle Creek (Details)

v3.25.2

Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Castle Creek (Details) $ / shares in Units, $ in Thousands	1 Months Ended	6 Months Ended
	Feb. 28, 2025 USD ($) $ / shares shares	Jun. 30, 2025 USD ($)	Jun. 30, 2024 USD ($)	Dec. 31, 2024 USD ($)
Agreements
Long-term royalty and commercial payment receivables under the cost recovery method		$ 58,937		$ 55,936
Short-term royalty and commercial payment receivables under the cost recovery method		700		$ 413
Payments of consideration under RPAs, AAAs and CPPAs		8,000	$ 37,000
Fair value of warrants		609
Royalty Financing Transaction \| Castle Creek Biosciences, Inc
Agreements
Rights entity acquired as a percentage of specified percentage	6.70%
Percentage of domestic sales	8.75%
Percentage of worldwide sales	8.00%
Percentage of proceeds from potential PRV	20.00%
Number of warrants received \| shares	10,464
Exercise price of warrants received (in dollars per share) \| $ / shares	$ 215.03
Term of warrants received	10 years
Aggregate purchase price	$ 5,000
Long-term royalty and commercial payment receivables under the cost recovery method	4,400
Short-term royalty and commercial payment receivables under the cost recovery method		0
Allowance for credit losses		0
Fair value of warrants	$ 600	$ 600
Period between issuance and expiration	2 years 9 months
Royalty Financing Transaction \| Castle Creek Biosciences, Inc \| Volatility
Agreements
Derivative Asset, Measurement Input	135
Royalty Financing Transaction \| Castle Creek Biosciences, Inc \| Risk-free interest rate
Agreements
Derivative Asset, Measurement Input	3.7

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479319/326-20-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479319/326-20-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479344/326-20-45-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479837/606-10-45-3

+ Details

Name:	us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value of input used to measure derivative asset.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 103
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-103

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_DerivativeAssetMeasurementInput
Namespace Prefix:	us-gaap_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480060/805-50-25-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 30
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480027/805-50-30-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Subparagraph (c)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-13

+ Details

Name:	us-gaap_PaymentsToAcquireProductiveAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of warrants or rights received during the period to purchase shares of counterparty under the agreement.

+ References

No definition available.

+ Details

Name:	xoma_AssetAcquisitionClassOfWarrantOrRightNumberReceived
Namespace Prefix:	xoma_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share of warrants or rights received to purchase shares of counterparty under the agreement.

+ References

No definition available.

+ Details

Name:	xoma_AssetAcquisitionClassOfWarrantOrRightPricePerShare
Namespace Prefix:	xoma_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Period over which entity has right to exercise warrants or rights received to purchase shares of counterparty under the agreement.

+ References

No definition available.

+ Details

Name:	xoma_AssetAcquisitionClassOfWarrantOrRightTerm
Namespace Prefix:	xoma_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the period between issuance and expiration of investment warrant.

+ References

No definition available.

+ Details

Name:	xoma_InvestmentWarrantTerm
Namespace Prefix:	xoma_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Fair value of investment in warrants, classified as noncurrent.

+ References

No definition available.

+ Details

Name:	xoma_InvestmentWarrantsNoncurrent
Namespace Prefix:	xoma_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of cash outflow for consideration under agreements, including Royalty Purchase Agreements (RPAs), Assignment and Assumption Agreements (AAAs), Commercial payment purchase agreement (CPPAs) and other agreements classified as investing activities. Payments may include upfront payments, one-time payments, milestone payments and contingent consideration payments.

+ References

No definition available.

+ Details

Name:	xoma_PaymentOfConsiderationUnderAgreementsInvestingActivities
Namespace Prefix:	xoma_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The rights entity acquired as a percentage of specified percentage of net sales or as a specified percentage of proceeds from potential Priority Review Voucher.

+ References

No definition available.

+ Details

Name:	xoma_RightsReceivablePercentageOnNetSalesAndProceeds
Namespace Prefix:	xoma_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The specified percentage of domestic net sales of which the entity received the right to receive a portion under the agreement, if amount is greater than international net sales.

+ References

No definition available.

+ Details

Name:	xoma_RightsReceivableSpecifiedPercentageOfNetSalesDomestic
Namespace Prefix:	xoma_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The specified percentage of international net sales of which the entity received right to receive a portion under the agreement, if amount is greater than domestic net sales.

+ References

No definition available.

+ Details

Name:	xoma_RightsReceivableSpecifiedPercentageOfNetSalesInternational
Namespace Prefix:	xoma_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The specified percentage of proceeds from a potential Priority Review Voucher of which the entity received right to receive a portion under the agreement.

+ References

No definition available.

+ Details

Name:	xoma_RightsReceivableSpecifiedPercentageOfProceeds
Namespace Prefix:	xoma_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Royalty and commercial payment receivables under cost recovery method probable and reasonably estimable to be received after one year or beyond the normal operating cycle, if longer.

+ References

No definition available.

+ Details

Name:	xoma_RoyaltyAndCommercialPaymentReceivablesCostRecoveryMethodLongTerm
Namespace Prefix:	xoma_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Royalty and commercial payment receivables under cost recovery method probable and reasonably estimable to be received within one year or the normal operating cycle, if longer.

+ References

No definition available.

+ Details

Name:	xoma_RoyaltyAndCommercialPaymentReceivablesCostRecoveryMethodShortTerm
Namespace Prefix:	xoma_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Details

Name:	us-gaap_TypeOfArrangementAxis=xoma_RoyaltyFinancingAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=xoma_CastleCreekBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: